These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21512034)

  • 21. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.
    She K; Yan H; Huang J; Zhou H; He J
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29131440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
    Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
    Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
    Liang YJ; Wang QY; Zhou CX; Yin QQ; He M; Yu XT; Cao DX; Chen GQ; He JR; Zhao Q
    Carcinogenesis; 2013 Mar; 34(3):713-22. PubMed ID: 23250910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach.
    Ouchida M; Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K
    PLoS One; 2012; 7(8):e44095. PubMed ID: 22952885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-125b targets ARID3B in breast cancer cells.
    Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
    Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
    Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
    Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
    Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
    Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
    Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H
    Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer.
    Li J; Kong F; Wu K; Song K; He J; Sun W
    Mol Med Rep; 2014 Nov; 10(5):2613-20. PubMed ID: 25215905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
    Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
    Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
    Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.
    Kaller M; Liffers ST; Oeljeklaus S; Kuhlmann K; Röh S; Hoffmann R; Warscheid B; Hermeking H
    Mol Cell Proteomics; 2011 Aug; 10(8):M111.010462. PubMed ID: 21566225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
    Wickramasinghe NS; Manavalan TT; Dougherty SM; Riggs KA; Li Y; Klinge CM
    Nucleic Acids Res; 2009 May; 37(8):2584-95. PubMed ID: 19264808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated miR-183 inhibits migration in breast cancer cells.
    Lowery AJ; Miller N; Dwyer RM; Kerin MJ
    BMC Cancer; 2010 Sep; 10():502. PubMed ID: 20858276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.